Tharimmune - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTharimmune
Tharimmune logo

Tharimmune

0 followers

HILS

Performance

About Tharimmune

Tharimmune, Inc. is a biotechnology company based in the U.S. focused on developing innovative therapeutics for rare immune, inflammatory, and oncologic diseases. The company is working on treating chronic pruritis related to primary biliary cholangitis and has an early-stage pipeline of immuno-oncology candidates, utilizing unique multi-specific antibodies. Tharimmune has partnered with OmniAb, Inc. for antibody discovery technology to enhance its research capabilities.

Recent News

Recent Deals

Key Team Members

Thomas Hess CPA

Chief Financial Officer

Randy Milby

CEO

Sireesh Appajosyula, PharmD

Chief Operating Officer

Key Facts

HQ Location

Bridgewater, United States

Founded

2017

Employees

1 - 10

Status

Public

Website

https://tharimmune.com